These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 11173326)

  • 1. The dyspepsia alphabet: DU, GU, GERD, NERD, NUD/FD and UD.
    Thomson AB
    Can J Gastroenterol; 2001 Jan; 15(1):49-55. PubMed ID: 11173326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low yield of endoscopy in patients with persistent dyspepsia taking proton pump inhibitors.
    Smith T; Verzola E; Mertz H
    Gastrointest Endosc; 2003 Jul; 58(1):9-13. PubMed ID: 12838213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Update on current care guidelines. A current care guideline: recurrent upper gastrointestinal symptoms].
    Paikka N
    Duodecim; 2012; 128(22):2376-7. PubMed ID: 23342484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic options in nonulcer dyspepsia.
    Talley NJ
    J Clin Gastroenterol; 2001 Apr; 32(4):286-93. PubMed ID: 11276271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yield of endoscopy in dyspepsia and concurrent treatment with proton pump inhibitors: the blind leading the blind?
    Talley NJ
    Gastrointest Endosc; 2003 Jul; 58(1):89-92. PubMed ID: 12838227
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect and cost-effectiveness of step-up versus step-down treatment with antacids, H2-receptor antagonists, and proton pump inhibitors in patients with new onset dyspepsia (DIAMOND study): a primary-care-based randomised controlled trial.
    van Marrewijk CJ; Mujakovic S; Fransen GA; Numans ME; de Wit NJ; Muris JW; van Oijen MG; Jansen JB; Grobbee DE; Knottnerus JA; Laheij RJ
    Lancet; 2009 Jan; 373(9659):215-25. PubMed ID: 19150702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [MODERN PROBLEMS OF DIAGNOSTICS AND TREATMENT OF FUNCTIONAL (UNULCEROUS) DYSPEPSIA].
    Skvortsov VV; Potapova MV; Skvortsov KY; Fedorova OF
    Eksp Klin Gastroenterol; 2016; (2):56-63. PubMed ID: 27301119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Functional dyspepsia: definition, classification, clinical and therapeutic management].
    Montalto M; Santoro L; Vastola M; Curigliano V; Cammarota G; Manna R; Gasbarrini G
    Ann Ital Med Int; 2004; 19(2):84-9. PubMed ID: 15317268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical inquiries. Is therapy based on endoscopy results better than empiric therapy for dyspepsia?
    Rich K; Safranek S; Malaty W
    J Fam Pract; 2005 Aug; 54(8):725-6. PubMed ID: 16061065
    [No Abstract]   [Full Text] [Related]  

  • 10. Functional dyspepsia: new insights into pathogenesis and therapy.
    Talley NJ
    Korean J Intern Med; 2016 May; 31(3):444-56. PubMed ID: 27048251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dyspepsia and reflux in primary care: rough DIAMOND of a trial.
    van Zanten SV
    Lancet; 2009 Jan; 373(9659):187-8. PubMed ID: 19150689
    [No Abstract]   [Full Text] [Related]  

  • 12. Dyspepsia: soothing the sour stomach.
    Johns Hopkins Med Lett Health After 50; 2000 Mar; 12(1):6-7. PubMed ID: 10740444
    [No Abstract]   [Full Text] [Related]  

  • 13. [Symptomatic treatment of dyspepsia in patients with digestive system diseases].
    Tkachev AV
    Eksp Klin Gastroenterol; 2006; (6):56-60. PubMed ID: 17612097
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnosis and management of dyspepsia--clinical guideline, 1999. Dyspepsia Working Group, South African Medical Association, South African Gastroenterology Society Working Group.
    S Afr Med J; 1999 Aug; 89(8 Pt 2):897-903. PubMed ID: 10488367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An update on current pharmacotherapy options for dyspepsia.
    Moshiree B; Barboza J; Talley N
    Expert Opin Pharmacother; 2013 Sep; 14(13):1737-53. PubMed ID: 23777571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Empirical H2 blocker therapy or prompt endoscopy in the management of dyspepsia.
    Fennerty MB
    Gastrointest Endosc; 1995 May; 41(5):529-30. PubMed ID: 7615245
    [No Abstract]   [Full Text] [Related]  

  • 17. Differences in the diagnostic yield of upper gastrointestinal endoscopy in dyspeptic patients receiving proton-pump inhibitors and H2-receptor antagonists.
    Mitchell RM; Collins JS; Watson RG; Tham TC
    Endoscopy; 2002 Jul; 34(7):524-6. PubMed ID: 12170401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Symptom overlaps between functional heartburn, functional dyspepsia, and irritable bowel syndrome].
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 May; 45(3):489-92. PubMed ID: 24941825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Observational comparative trial of the efficacy of proton pump inhibitors versus histamine-2 receptor antagonists for uninvestigated dyspepsia.
    Nagahara A; Asaoka D; Hojo M; Oguro M; Shimada Y; Ishikawa D; Osada T; Kawabe M; Yoshizawa T; Otaka M; Watanabe S
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S122-8. PubMed ID: 20586853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gastroesophageal reflux disease and dyspepsia--drug therapy].
    Gräter H
    Praxis (Bern 1994); 2006 Aug; 95(31-32):1179-83. PubMed ID: 16909686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.